Publications by authors named "Corrado Sardella"
Article Synopsis
- Convalescent plasma (CP) has been utilized since April 2020 in the Veneto region of Italy as a treatment for severe COVID-19, targeting patients with high-titre neutralizing antibodies.
- Among 1,517 COVID-19 inpatients treated, 14% (209 patients) died within 30 days, with mortality linked to factors like advanced age, pre-existing conditions, and severe respiratory distress.
- The study emphasized that worse outcomes were associated with patients exhibiting lower oxygen levels and rapid breathing at the time of treatment.
Background: The optimal duration of thromboprophylaxis after major orthopedic surgery is controversial. Although oral anticoagulants are still widely used for the prevention of venous thromboembolism after hip replacement, to our knowledge no study has assessed the benefit of prolonging anticoagulation beyond the hospital stay.
Methods: Consecutive patients who had received warfarin sodium prophylaxis after total hip arthroplasty were randomized to stop taking the drug at the time of hospital discharge or to continue taking it for 4 more weeks.